THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 143 filers reported holding THERAVANCE INC in Q3 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $3,287,000 | +143.3% | 232,282 | +193.9% | 0.05% | +130.0% |
| Q3 2014 | $1,351,000 | -82.2% | 79,034 | -69.0% | 0.02% | -83.1% |
| Q2 2014 | $7,588,000 | +70.9% | 254,813 | +77.6% | 0.12% | +63.9% |
| Q1 2014 | $4,439,000 | +156.3% | 143,447 | +195.3% | 0.07% | +111.8% |
| Q4 2013 | $1,732,000 | -26.2% | 48,575 | +59.4% | 0.03% | -35.8% |
| Q3 2013 | $2,347,000 | +37.1% | 30,477 | -31.4% | 0.05% | +32.5% |
| Q2 2013 | $1,712,000 | – | 44,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 20,144,301 | $718,144,000 | 20.35% |
| Litespeed Management, L.L.C. | 1,636,994 | $58,359,000 | 8.44% |
| Realm Partners LLC | 240,794 | $8,585,000 | 7.27% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,828,059 | $100,820,000 | 4.97% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,456,503 | $265,824,000 | 3.15% |
| SECTORAL ASSET MANAGEMENT INC | 1,973,188 | $70,344,000 | 3.03% |
| Foundation Asset Management, LP | 221,796 | $7,907,000 | 2.06% |
| Rhenman & Partners Asset Management AB | 132,000 | $4,706,000 | 1.84% |
| BB BIOTECH AG | 888,244 | $31,666,000 | 1.69% |
| HealthCor Management, L.P. | 725,000 | $25,846,000 | 1.57% |